Position history for BlackRock Finance, Inc.'s holdings in REGENERON PHARMACEUTICALS
BlackRock Finance, Inc. holds 8.4M shares of REGN (REGENERON PHARMACEUTICALS), worth $8.9B as of 2024-Q2. The position was decreased (-1.4% shares). REGN represents 0.2% of BlackRock Finance, Inc.'s portfolio.
Current Value
$8.9B
Current Shares
8.4M
Total Value Change
$0
Total Shares Change
0
Other major holders of REGN: VANGUARD GROUP INC, BlackRock, Inc.
Upgrade to Pro to see multi-quarter position history and trends. View plans
Decreased |
| 8.4M |
-1.4% |
| $8.9B |
| 0.2% |
| $1,045.23 |
0 |